DF Dent & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.68M | Sell |
18,593
-660
| -3% | -$55.3K | 0.03% | 145 |
|
|
2026
Q1 | $1.54M | Sell |
19,253
-2,720
| -12% | -$224K | 0.03% | 141 |
|
|
2025
Q4 | $1.87M | Sell |
21,973
-755
| -3% | -$62K | 0.03% | 141 |
|
|
2025
Q3 | $1.77M | Sell |
22,728
-72
| -0.3% | -$5.63K | 0.02% | 137 |
|
|
2025
Q2 | $1.78M | Sell |
22,800
-1,653
| -7% | -$123K | 0.02% | 135 |
|
|
2025
Q1 | $1.77M | Sell |
24,453
-517,684
| -95% | -$37.1M | 0.02% | 137 |
|
|
2024
Q4 | $40.1M | Sell |
542,137
-1,736
| -0.3% | -$122K | 0.51% | 52 |
|
|
2024
Q3 | $35.9M | Sell |
543,873
-109,330
| -17% | -$7.94M | 0.44% | 56 |
|
|
2024
Q2 | $60.3M | Sell |
653,203
-24,111
| -4% | -$2.14M | 0.78% | 40 |
|
|
2024
Q1 | $64.7M | Buy |
677,314
+3,773
| +0.6% | +$317K | 0.79% | 40 |
|
|
2023
Q4 | $51.4M | Buy |
673,541
+100,287
| +17% | +$6.98M | 0.68% | 46 |
|
|
2023
Q3 | $39.7M | Buy |
573,254
+121,580
| +27% | +$9.77M | 0.58% | 46 |
|
|
2023
Q2 | $42.6M | Sell |
451,674
-21,069
| -4% | -$1.83M | 0.58% | 47 |
|
|
2023
Q1 | $39.1M | Sell |
472,743
-3,638
| -0.8% | -$286K | 0.55% | 49 |
|
|
2022
Q4 | $35.5M | Buy |
476,381
+441,702
| +1,274% | +$34M | 0.53% | 49 |
|
|
2022
Q3 | $2.87M | Sell |
34,679
-849
| -2% | -$81.7K | 0.04% | 107 |
|
|
2022
Q2 | $3.38M | Buy |
35,528
+330
| +0.9% | +$34.2K | 0.05% | 102 |
|
|
2022
Q1 | $4.14M | Hold |
35,198
| – | – | 0.05% | 102 |
|
|
2021
Q4 | $4.56M | Buy |
35,198
+35
| +0.1% | +$4.08K | 0.05% | 102 |
|
|
2021
Q3 | $3.98M | Sell |
35,163
-50
| -0.1% | -$5.71K | 0.04% | 101 |
|
|
2021
Q2 | $3.65M | Sell |
35,213
-60
| -0.2% | -$5.66K | 0.04% | 102 |
|
|
2021
Q1 | $2.95M | Buy |
35,273
+810
| +2% | +$68.5K | 0.03% | 105 |
|
|
2020
Q4 | $3.14M | Hold |
34,463
| – | – | 0.04% | 101 |
|
|
2020
Q3 | $2.75M | Buy |
34,463
+365
| +1% | +$28.5K | 0.04% | 99 |
|
|
2020
Q2 | $2.36M | Hold |
34,098
| – | – | 0.04% | 99 |
|
|
2020
Q1 | $2.14M | Buy |
34,098
+510
| +2% | +$36.8K | 0.04% | 100 |
|
|
2019
Q4 | $2.61M | Sell |
33,588
-5,700
| -15% | -$445K | 0.04% | 106 |
|
|
2019
Q3 | $2.88M | Hold |
39,288
| – | – | 0.05% | 97 |
|
|
2019
Q2 | $2.42M | Hold |
39,288
| – | – | 0.04% | 111 |
|
|
2019
Q1 | $2.51M | Sell |
39,288
-5,355
| -12% | -$306K | 0.05% | 109 |
|
|
2018
Q4 | $2.28M | Sell |
44,643
-600
| -1% | -$30.4K | 0.06% | 82 |
|
|
2018
Q3 | $2.63M | Buy |
45,243
+5,025
| +12% | +$246K | 0.05% | 87 |
|
|
2018
Q2 | $1.95M | Hold |
40,218
| – | – | 0.04% | 101 |
|
|
2018
Q1 | $1.87M | Hold |
40,218
| – | – | 0.04% | 98 |
|
|
2017
Q4 | $1.51M | Sell |
40,218
-75
| -0.2% | -$2.75K | 0.04% | 86 |
|
|
2017
Q3 | $1.47M | Buy |
40,293
+2,775
| +7% | +$106K | 0.04% | 82 |
|
|
2017
Q2 | $1.48M | Buy |
37,518
+15,375
| +69% | +$561K | 0.04% | 79 |
|
|
2017
Q1 | $694K | Buy |
+22,143
| New | +$693K | 0.02% | 99 |
|
Other funds holding EW
DF Dent & Co's EW Position: Q2 2026 in Review
DF Dent & Co reduced its Edwards Lifesciences (EW) stake by 3.4% in Q2 2026, selling an estimated $55.3K and leaving 18,593 shares worth $1.68M. The position accounts for 0.03% of the portfolio, ranked #145.
DF Dent & Co first reported a position in EW in Q1 2017 and has held it in 38 quarters since. The position peaked at $64.7M in Q1 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- DF Dent & Co held 18,593 shares of Edwards Lifesciences worth $1.68M as of Q2 2026.
- DF Dent & Co sold 660 Edwards Lifesciences shares in Q2 2026, an estimated $55.3K.
- Edwards Lifesciences made up 0.03% of DF Dent & Co's portfolio in Q2 2026, its #145 holding.
- DF Dent & Co first reported a position in Edwards Lifesciences in Q1 2017 and has held it in 38 quarters since.
- DF Dent & Co's Edwards Lifesciences position peaked at $64.7M in Q1 2024.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on DF Dent & Co's 13F filing for Q2 2026, filed 14 Aug 2026.